Plk3 Enhances Cisplatin Sensitivity of Nonsmall-Cell Lung Cancer Cells through Inhibition of the PI3K/AKT Pathway <i>via</i> Stabilizing PTEN-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plk3 Enhances Cisplatin Sensitivity of Nonsmall-Cell Lung Cancer Cells through Inhibition of the PI3K/AKT Pathway via Stabilizing PTEN

Published:2024-02-12 Issue:8 Volume:9 Page:8995-9002
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Xu Mengshan¹,Deng Xiaoyun²,Xiang Nana³,Zhang Zhao¹,Yang Min²,Liu Qinxiang²^ORCID

Affiliation:

1. Breast Tumor Center, Hainan Provincial Tumor Hospital, Haikou 570312, Hainan, China

2. Department of Medical Oncology, Hainan Provincial Tumor Hospital, Haikou 570312, Hainan, China

3. Department of Medical Oncology, Luoyang Central Hospital, Luoyang 471001, Henan, China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c07271

Reference31 articles.

1. Current status of immunotherapy for non-small cell lung cancer

2. Current Diagnosis and Management of Small-Cell Lung Cancer

3. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer

4. Polo-like kinase 3, hypoxic responses, and tumorigenesis

5. Roles of Polo-like kinase 3 in suppressing tumor angiogenesis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP